LINC00355, also named as lnc-PCDH9-13:1, has been found to abnormally expressed in multiple malignancies such as esophageal squamous cell carcinoma (33), papillary renal cell carcinoma (34), and hepatocellular carcinoma (HCC) (35). This evidence concerns the gene PCDH9 and hepatocellular carcinoma.